Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NY:
ZYME
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zymeworks Inc
< Previous
1
2
3
4
Next >
Zymeworks To Host Second Quarter 2023 Results Conference Call
July 19, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conference
July 03, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Appoints New Director
June 29, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
June 26, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
June 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
May 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
May 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks To Host First Quarter 2023 Results Conference Call
April 17, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
April 10, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
April 03, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Offers Hope for More than Just Long-Term Investors
March 09, 2023
Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher
Via
MarketBeat
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
February 28, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
February 21, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
January 25, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023
January 04, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conference
December 21, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Positive Topline Data in the Pivotal HERIZON-BTC-01 Trial of Zanidatamab
December 19, 2022
From
Zymeworks Inc.
Via
Business Wire
Zanidatamab Clinical Data Selected For Presentation At The American Society Of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
December 14, 2022
From
Zymeworks Inc.
Via
Business Wire
New Clinical Data for Zanidatamab in HER2+ /HR+ Metastatic Breast Cancer Presented Today at 2022 SABCS
December 09, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks to Transfer Stock Listing to Nasdaq
December 05, 2022
From
Zymeworks Inc.
Via
Business Wire
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
November 30, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END
Via
FinancialNewsMedia
Zymeworks Announces Expiration of Hart-Scott-Rodino Waiting Period for Zanidatamab License Agreement with Jazz Pharmaceuticals
November 29, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conference
November 22, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Abstract For Zanidatamab In Late-Line HER2-Positive Hormone-Receptor Positive (HR+) Metastatic Breast Cancer At The San Antonio Breast Cancer Symposium (SABCS)
November 21, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 08, 2022
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Early R&D Day Highlights Progress in Development of Novel Pipeline Assets and Applications of Proprietary Next-Generation Technology Platforms
October 20, 2022
From
Zymeworks Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.